CD8A and tuberculosis: In summary, this research aims to pinpoint potential ICs that modulate the cytotoxic activity of CD8+ T cells in TB patients by systematically analyzing multi-center TB databases, thereby providing more reference for anti-TB immunotherapy targeting the reversal of CD8+ T cell immune function.